Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1Z89
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,876
Award facts
- Contract value 100% obligated
- $24,876.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24.88K delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Tagrisso 80 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with performance through February 26, 2026, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $1.0 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and other government healthcare systems. The company's extensive federal contracting portfolio demonstrates its capability to supply diverse pharmaceutical products including specialty medications, vaccines, generic and brand-name drugs, and medical devices across multiple therapeutic domains. The non-set-aside status of this award reflects AmerisourceBergen's competitive position within open federal procurement for essential pharmaceutical commodities supporting military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F1Z89?
SPE2DR26F1Z89 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F1Z89 worth?
The government has obligated $24,876 on SPE2DR26F1Z89.
Is contract SPE2DR26F1Z89 an order under another contract?
Yes. SPE2DR26F1Z89 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Z89 competed?
The extent of competition for SPE2DR26F1Z89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award